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EDITORIAL COMMENT
Endocarditis Beyond the
Annulus: Eat Your Heart Out*
Ann F. Bolger, MD, FACC
San Francisco, California
Endocarditis is on the rise. Between 15,000 to 20,000 new
cases are diagnosed each year, exposing patients to a high risk
of morbidity and mortality. The diagnosis, therapy and prog-
nosis of endocarditis also seem to be moving targets, as new
options for imaging and treatment come into clinical practice.
Early precise diagnosis and identification of clinically signifi-
cant complications is critical to best patient management. The
last decade has seen tremendous advances in early diagnosis,
based largely on the increasing sensitivity and specificity of
transesophageal echocardiography (TEE). The Duke criteria
for the diagnosis of infective endocarditis (IE) (1) have for-
malized the role of echocardiographic findings into the diag-
nostic strategy for IE. Although our clinical reliance on
echocardiographic methods has increased, it remains a vexing
problem that echocardiographic findings are not perfect pre-
dictors of some of the most clinically dangerous complications
of IE, particularly embolization and perivalvular extension of
infection.
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Perivalvular extension of endocarditis is associated with
more complications, including heart failure and need for
surgery, and poorer outcome of patients with endocarditis
(2–4). Recognition of abscesses, fistulous tracts and perival-
vular leaks is much better with TEE compared to transtho-
racic echocardiographic approaches and continues to im-
prove as echocardiographic technology advances. Higher
spatial and temporal resolution, better near-field visualiza-
tion and multiple planes all assist in defining anatomy and
avoiding confusion from artifacts and interference. How-
ever, technology-based advances are incorporated into gen-
eral clinical practice over time in an unpredictable fashion.
Many of the most important clinical studies on patients with
IE have been based on retrospective data. It is sometimes
difficult to extrapolate data from those studies—collected often
over many years using a broad range of echocardiographic
equipment and methods—to current clinical practice based on
ever-improving echocardiographic technology. Prospective
data acquired over relatively short time intervals is highly
valuable, because it narrows the range of equipment and
technique and minimizes the effects of variable sensitivity and
specificity due to imaging practice over time.
The study reported in this issue of the Journal, by Graupner
et al. (5) at five centers in Spain and Argentina, is both large
and prospective. Perivalvular extension of infection (PVEI) was
sought prospectively in 211 patients with left-sided endocar-
ditis using current transthoracic and transesophageal echocar-
diographic methods. Their data include a mix of imaging
approaches performed with single, biplane and multiplane
probes on a variety of echocardiography machines; the data are
applicable to the common current spectrum of equipment in
current clinical use. With that relatively current equipment and
approach, they documented eight perivalvular abscesses that
were missed with TEE but confirmed at surgery. The use of
single, biplane or multiplane probes did not seem to relate to
the incidence of these false-negative TEE studies. Review of
the false-negative cases showed that three of eight missed
abscesses were recognizable as periannular thickening, which
fell short of the investigators’ cutoff value of 10 mm of reduced
echocardiographic density for diagnosis of an abscess. While
their data do not clarify whether this may relate to imaging at
an early stage of infection, it is increasingly common to do
TEE very early on in the clinical course, since initial TEE in
patients with Staphylococcus bacteremia has been suggested to
be cost-effective (6). In general, TEE has had good but not
perfect sensitivity and specificity for PVEI (76% to 100%),
with positive and negative predictive values of 87% and 89%,
respectively (7–9). Future study will be needed to clarify
whether very early TEE may create some increased risk of
missed PVEI. Progression of an abscess to pseudoaneurysm
may improve reliability; in the present study (5) no pseudo-
aneurysms were missed, likely because the characteristic flow
pattern in those regions increases their ease of detection.
Prosthetic valves are strongly associated with perivalvular
infection (10), and they present many technical challenges
to both transthoracic and transesophageal imaging. Inter-
ference from prosthetic materials, pledgets around the
annular ring, and the complicated distribution of closing
jets, particularly from mechanical prostheses, provide a large
number of potentially confusing artifacts and findings. The
best approach is thorough interrogation from as many planes as
possible, and having skilled operators with experience in
visualizing these prostheses. Many prosthetic valves have small,
stable perivalvular leaks originating at or between suture sites at
the sewing ring, which are visible on TEE from the time of
implantation. Without baseline postoperative images, it may
be very difficult to tell these from small perivalvular leaks
related to infection. Similarly, regions of the coronary sinuses
may appear in some views to be periannular spaces, and their
flow misinterpreted as flow in a pseudoaneurysm. Avoiding
these imaging pitfalls is important. Low confidence views and
studies may need to be repeated, particularly if the patient is
doing well in other regards.
The reliability of our clinical tools and effectiveness of our
treatment strategies may vary depending upon the specific
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bacteriology, underlying substrate for infection, and the
location and extent of the endothelial infection in each
patient. The patients in the present study (5) were middle-
aged or older, and they had a very low incidence of
intravenous (IV) substance abuse. They also had a low
incidence of underlying immunodeficiency. This is very
different from the demographics of many endocarditis
populations and is in clear distinction from the inner-city
mix of patients, which includes a much greater proportion
of IV drug users, and a significant proportion of patients
with underlying HIV, chronic hepatitis and uncontrolled
medical co-morbidities. The extent to which those clinical
characteristics increase the frequency of PVEI and modify
the clinical course cannot be extrapolated from these data,
but other studies have shown active IV drug use to be
positively associated with PVEI in multivariate analysis (4).
One of the most striking findings of the Graupner et al.
(5) study is that patients who required surgery generally had
congestive heart failure (CHF) or persistent signs of infec-
tion in addition to their perivalvular infection. Perivalvular
infections in the absence of CHF, persistent infection or severe
valvular insufficiency alone accounted for surgery in only three
patients. These complications often coexist. The perioperative
mortality among the patients with PVEI in this series was
quite high (36.1%). The mortality among patients with PVEI
who did not undergo surgery was not different (35.3%).
Do these results imply that we should develop a “wait and
see” attitude toward PVEI? Data from several surgical
groups suggest that operative survival is heavily influenced
not only by CHF but also by advanced age and other
medical co-morbidities, including renal failure and cerebro-
vascular events. Operative mortality of patients with IE has
been estimated to increase threefold in the presence of heart
failure from any mechanism (11–13). It seems important to
remember that the comparative risk of reinfection of newly
implanted valves in actively infected patients (2% to 3%) is
far less than the risk associated with waiting until CHF
appears to progress to surgery (14,15).
In summary, the presentation, course, and the therapy of
endocarditis is profoundly influenced by patient demo-
graphics, including predisposing cardiac conditions and
risky behaviors. Large series of patients are hard to come by,
and rapidly changing diagnostic tools as well as variable
patient populations make retrospective studies difficult to
compare. The work by Graupner et al. (5) provides us with
new data that are most representative of current echocar-
diographic practice in a non-drug-abusing older adult pop-
ulation. These data complement other large series culled
from younger, more high-risk populations. The observation
that some patients from their population improved with
medical management alone is intriguing, and confirms
earlier studies (16,17). Early surgery has been shown to
improve the mortality of complicated endocarditis, however,
and strategies that delay surgical decisions until the appear-
ance of heart failure are associated with poorer outcomes.
For some patients with high risk for surgery—for exam-
ple, owing to coexisting medical illnesses, repetitive pros-
thetic infection or ongoing IV drug use—medical therapy of
PVEI has some possibility of success. Whether there is a
safe strategy for nonsurgical management in patients with
PVEI who would otherwise be surgical candidates remains
to be proven, although it would clearly be restricted to cases
without heart failure, severe valvular insufficiency or exten-
sive infections. In cases where medical management is
elected for whatever reason, serial transesophageal imaging
can be used to closely follow valvular and ventricular
function and abscess size. The long-term sequelae of unop-
erated abscesses or pseudoaneurysms, including progression,
heart failure or reinfection, must await future study.
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